221 related articles for article (PubMed ID: 29078264)
1. Overview of Ganoderma sinense polysaccharide-an adjunctive drug used during concurrent Chemo/Radiation therapy for cancer treatment in China.
Jiang Y; Chang Y; Liu Y; Zhang M; Luo H; Hao C; Zeng P; Sun Y; Wang H; Zhang L
Biomed Pharmacother; 2017 Dec; 96():865-870. PubMed ID: 29078264
[TBL] [Abstract][Full Text] [Related]
2. Ganoderma sinense polysaccharide: An adjunctive drug used for cancer treatment.
Zhang Y; Jiang Y; Zhang M; Zhang L
Prog Mol Biol Transl Sci; 2019; 163():165-177. PubMed ID: 31030747
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for Poria cocos mushroom polysaccharide used as an antitumor drug in China.
Li X; Ma L; Zhang L
Prog Mol Biol Transl Sci; 2019; 163():263-296. PubMed ID: 31030751
[TBL] [Abstract][Full Text] [Related]
4. Ganoderma lucidum polysaccharide used for treating physical frailty in China.
Zeng P; Chen Y; Zhang L; Xing M
Prog Mol Biol Transl Sci; 2019; 163():179-219. PubMed ID: 31030748
[TBL] [Abstract][Full Text] [Related]
5. Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China.
Zeng P; Guo Z; Zeng X; Hao C; Zhang Y; Zhang M; Liu Y; Li H; Li J; Zhang L
J Cell Mol Med; 2018 Jul; 22(7):3278-3297. PubMed ID: 29691994
[TBL] [Abstract][Full Text] [Related]
6. GSP-2, a polysaccharide extracted from Ganoderma sinense, is a novel toll-like receptor 4 agonist.
Liu KS; Zhang C; Dong HL; Li KK; Han QB; Wan Y; Chen R; Yang F; Li HL; Ko CH; Han XQ
PLoS One; 2019; 14(8):e0221636. PubMed ID: 31442262
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro.
Yue GG; Fung KP; Tse GM; Leung PC; Lau CB
J Altern Complement Med; 2006 Oct; 12(8):777-89. PubMed ID: 17034284
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China.
Li X; He Y; Zeng P; Liu Y; Zhang M; Hao C; Wang H; Lv Z; Zhang L
J Cell Mol Med; 2019 Jan; 23(1):4-20. PubMed ID: 30444050
[TBL] [Abstract][Full Text] [Related]
9. The biological activities of the antitumor drug Grifola frondosa polysaccharide.
He Y; Zhang L; Wang H
Prog Mol Biol Transl Sci; 2019; 163():221-261. PubMed ID: 31030750
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Review on the Chemical Composition, Pharmacology and Clinical Applications of
Liu C; Song X; Li Y; Ding C; Li X; Dan L; Xu H; Zhang D
Am J Chin Med; 2023; 51(8):1983-2040. PubMed ID: 37903715
[No Abstract] [Full Text] [Related]
11. Screening and analysis of potential anti-tumor components from the stipe of Ganoderma sinense using high-performance liquid chromatography/time-of-flight mass spectrometry with multivariate statistical tool.
Chan KM; Yue GG; Li P; Wong EC; Lee JK; Kennelly EJ; Lau CB
J Chromatogr A; 2017 Mar; 1487():162-167. PubMed ID: 28143662
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of Polyporus Umbellatus polysaccharide in treating hepatitis B in China.
Guo Z; Zang Y; Zhang L
Prog Mol Biol Transl Sci; 2019; 163():329-360. PubMed ID: 31030753
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of bioactive polysaccharides from Ganoderma lucidum (Lingzhi), a review.
Lu J; He R; Sun P; Zhang F; Linhardt RJ; Zhang A
Int J Biol Macromol; 2020 May; 150():765-774. PubMed ID: 32035956
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization and immuno-modulating activities of a polysaccharide from Ganoderma sinense.
Han XQ; Chan BC; Yu H; Yang YH; Hu SQ; Ko CH; Dong CX; Wong CK; Shaw PC; Fung KP; Leung PC; Hsiao WL; Tu PF; Han QB
Int J Biol Macromol; 2012 Nov; 51(4):597-603. PubMed ID: 22750578
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Chemical Profiles and Antioxidant and Antidiabetic Activities of Extracts from Two Ganoderma Species (Agaricomycetes).
Tang X; Cai W; Xu B
Int J Med Mushrooms; 2016; 18(7):609-20. PubMed ID: 27649729
[TBL] [Abstract][Full Text] [Related]
16. Protective Effect of Ganoderma (Lingzhi) on Radiation and Chemotherapy.
Chen L; Abulizi A; Li M
Adv Exp Med Biol; 2019; 1182():119-142. PubMed ID: 31777016
[TBL] [Abstract][Full Text] [Related]
17. Ganodermataceae: natural products and their related pharmacological functions.
Zhou X; Lin J; Yin Y; Zhao J; Sun X; Tang K
Am J Chin Med; 2007; 35(4):559-74. PubMed ID: 17708623
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two officinal Chinese pharmacopoeia species of Ganoderma based on chemical research with multiple technologies and chemometrics analysis.
Da J; Wu WY; Hou JJ; Long HL; Yao S; Yang Z; Cai LY; Yang M; Jiang BH; Liu X; Cheng CR; Li YF; Guo DA
J Chromatogr A; 2012 Jan; 1222():59-70. PubMed ID: 22226558
[TBL] [Abstract][Full Text] [Related]
19. A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide.
Liu X; Yang L; Li G; Jiang Y; Zhang G; Ling J
Int J Biol Macromol; 2023 Feb; 229():168-180. PubMed ID: 36587634
[TBL] [Abstract][Full Text] [Related]
20. A comparative study on immunomodulatory activity of polysaccharides from two official species of Ganoderma (Lingzhi).
Meng LZ; Xie J; Lv GP; Hu DJ; Zhao J; Duan JA; Li SP
Nutr Cancer; 2014; 66(7):1124-31. PubMed ID: 25204488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
